Vtv Therapeutics Inc. current report, 13 December 2023

Business Context and Reporting Period

This Form 8-K was filed by vTv Therapeutics Inc. on December 19, 2023, reporting an event that occurred on December 13, 2023. The Company is incorporated in Delaware and its Class A common stock (trading symbol: VTVT) is listed on the Nasdaq Capital Market.

Key Financial Metrics

This filing is a current report regarding listing compliance and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for these metrics.

Material Changes

The material event reported is a notice of non-compliance with Nasdaq listing standards:

  • Violation: The Company failed to meet Nasdaq Listing Rule 5550(b)(2) regarding the Market Value of Listed Securities (MVLS).
  • Threshold: The MVLS has been below the required $35 million for the last 30 consecutive business days.
  • Consequence: The Company received a formal notice from The Nasdaq Stock Market LLC on December 13, 2023.

Outlook, Risks, and Management Commentary

Compliance Period: The Company has been granted 180 calendar days (until June 10, 2024) to regain compliance.

Path to Compliance: The Company can regain compliance without further action if the MVLS closes at or above $35 million for a minimum of 10 consecutive business days during the compliance period.

Management Action: Management intends to actively monitor the MVLS and is evaluating available options to regain compliance.

Risks: There is no assurance that the Company will regain compliance. If compliance is not achieved by the deadline, subject to an appeals process, the Class A Common Stock will be subject to delisting and removal from the Nasdaq Capital Market.

Investor Verification Checklist

  • Verify the current Market Value of Listed Securities (MVLS) to assess proximity to the $35 million threshold.
  • Monitor the Company's stock price performance over the next 10 consecutive business days to determine if automatic compliance is achieved.
  • Review future filings for any announced capital raising activities or strategic actions intended to increase market value.
  • Check for any updates regarding the Company's appeal rights should the 180-day period expire without compliance.